(CHH) Choice Hotels International - Ratings and Ratios
Hotel Franchising, Brand Licensing, Property Management
Dividends
| Dividend Yield | 1.31% |
| Yield on Cost 5y | 1.14% |
| Yield CAGR 5y | 39.90% |
| Payout Consistency | 66.8% |
| Payout Ratio | 16.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.4% |
| Value at Risk 5%th | 43.9% |
| Relative Tail Risk | -2.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.83 |
| Alpha | -53.44 |
| CAGR/Max DD | -0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.274 |
| Beta | 0.769 |
| Beta Downside | 0.691 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.83% |
| Mean DD | 11.67% |
| Median DD | 9.62% |
Description: CHH Choice Hotels International November 06, 2025
Choice Hotels International (NYSE: CHH) is a global hotel franchisor headquartered in North Bethesda, Maryland, operating two primary segments: Hotel Franchising & Management and Corporate & Other. The company licenses a broad portfolio of mid-scale and upscale brands-including Comfort Inn, Quality, Clarion, Econo Lodge, and the Radisson family-across the United States and more than 40 international markets.
Key performance indicators that investors watch include the franchise-related revenue per available room (RevPAR) growth, which averaged a 4.2% year-over-year increase in Q2 2024, and the same-store occupancy rate, currently hovering around 71%-above the industry median of ~68% for the mid-scale segment. The business model benefits from a low-capital structure: roughly 85% of total revenue is franchise-related, limiting exposure to direct property operating costs.
Macro-economic drivers are critical. Domestic leisure travel demand remains buoyant as discretionary spending rebounds, while corporate travel is recovering slowly but unevenly, creating a “hybrid” occupancy pattern that favors flexible, franchised brands. Additionally, the ongoing shortage of hotel labor pushes operators toward franchise models that can leverage centralized marketing and technology platforms, such as Choice’s proprietary “Choice Central” system.
Given the company’s asset-light franchise model and its diversified brand slate, a deeper dive into its franchise fee structure and pipeline of new openings could clarify upside potential-consider exploring the detailed analytics on ValueRay for a data-rich perspective.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (382.1m TTM) > 0 and > 6% of Revenue (6% = 95.8m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 1.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.14% (prev -9.02%; Δ 7.88pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 267.6m <= Net Income 382.1m (YES >=105%, WARN >=100%) |
| Net Debt (1.98b) to EBITDA (637.4m) ratio: 3.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.5m) change vs 12m ago -1.56% (target <= -2.0% for YES) |
| Gross Margin 51.46% (prev 48.30%; Δ 3.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 58.57% (prev 61.06%; Δ -2.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.43 (EBITDA TTM 637.4m / Interest Expense TTM 88.5m) >= 6 (WARN >= 3) |
Altman Z'' 4.77
| (A) -0.01 = (Total Current Assets 450.3m - Total Current Liabilities 468.5m) / Total Assets 2.91b |
| (B) 0.78 = Retained Earnings (Balance) 2.27b / Total Assets 2.91b |
| (C) 0.21 = EBIT TTM 569.5m / Avg Total Assets 2.73b |
| (D) 0.82 = Book Value of Equity 2.26b / Total Liabilities 2.76b |
| Total Rating: 4.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.84
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.48% |
| 3. FCF Margin 13.19% |
| 4. Debt/Equity 13.54 |
| 5. Debt/Ebitda 3.10 |
| 6. ROIC - WACC (= 19.77)% |
| 7. RoE data missing |
| 8. Rev. Trend 57.31% |
| 9. EPS Trend 68.02% |
What is the price of CHH shares?
Over the past week, the price has changed by -3.73%, over one month by -3.98%, over three months by -24.78% and over the past year by -41.24%.
Is CHH a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 9
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the CHH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109.3 | 24.4% |
| Analysts Target Price | 109.3 | 24.4% |
| ValueRay Target Price | 73.4 | -16.5% |
CHH Fundamental Data Overview December 05, 2025
P/E Trailing = 10.8335
P/E Forward = 13.0208
P/S = 4.9602
P/B = 28.3183
P/EG = 1.3016
Beta = 0.799
Revenue TTM = 1.60b USD
EBIT TTM = 569.5m USD
EBITDA TTM = 637.4m USD
Long Term Debt = 1.92b USD (from longTermDebt, last quarter)
Short Term Debt = 5.37m USD (from shortTermDebt, last fiscal year)
Debt = 2.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 6.04b USD (4.07b + Debt 2.03b - CCE 52.6m)
Interest Coverage Ratio = 6.43 (Ebit TTM 569.5m / Interest Expense TTM 88.5m)
FCF Yield = 3.48% (FCF TTM 210.5m / Enterprise Value 6.04b)
FCF Margin = 13.19% (FCF TTM 210.5m / Revenue TTM 1.60b)
Net Margin = 23.93% (Net Income TTM 382.1m / Revenue TTM 1.60b)
Gross Margin = 51.46% ((Revenue TTM 1.60b - Cost of Revenue TTM 774.9m) / Revenue TTM)
Gross Margin QoQ = 53.49% (prev 53.39%)
Tobins Q-Ratio = 2.08 (Enterprise Value 6.04b / Total Assets 2.91b)
Interest Expense / Debt = 1.16% (Interest Expense 23.5m / Debt 2.03b)
Taxrate = 14.66% (30.9m / 210.9m)
NOPAT = 486.0m (EBIT 569.5m * (1 - 14.66%))
Current Ratio = 0.96 (Total Current Assets 450.3m / Total Current Liabilities 468.5m)
Debt / Equity = 13.54 (Debt 2.03b / totalStockholderEquity, last quarter 149.8m)
Debt / EBITDA = 3.10 (Net Debt 1.98b / EBITDA 637.4m)
Debt / FCF = 9.38 (Net Debt 1.98b / FCF TTM 210.5m)
Total Stockholder Equity = 3.58m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.14% (Net Income 382.1m / Total Assets 2.91b)
RoE = 10.7k% (out of range, set to none) (Net Income TTM 382.1m / Total Stockholder Equity 3.58m)
RoCE = 29.63% (EBIT 569.5m / Capital Employed (Equity 3.58m + L.T.Debt 1.92b))
RoIC = 26.00% (NOPAT 486.0m / Invested Capital 1.87b)
WACC = 6.23% (E(4.07b)/V(6.09b) * Re(8.85%) + D(2.03b)/V(6.09b) * Rd(1.16%) * (1-Tc(0.15)))
Discount Rate = 8.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.14%
[DCF Debug] Terminal Value 71.26% ; FCFE base≈179.9m ; Y1≈143.4m ; Y5≈96.7m
Fair Price DCF = 33.78 (DCF Value 1.56b / Shares Outstanding 46.3m; 5y FCF grow -24.27% → 3.0% )
EPS Correlation: 68.02 | EPS CAGR: 22.21% | SUE: -1.01 | # QB: 0
Revenue Correlation: 57.31 | Revenue CAGR: 12.81% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.33 | Chg30d=-0.058 | Revisions Net=-3 | Analysts=8
EPS next Year (2026-12-31): EPS=7.17 | Chg30d=-0.074 | Revisions Net=-2 | Growth EPS=+3.3% | Growth Revenue=+2.2%
Additional Sources for CHH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle